Toxic Legacy: The Threat of PFAS Contamination from UK Military Bases

Per- and polyfluoroalkyl substances (PFAS), often referred to as “forever chemicals,” have emerged as one of the most persistent and hazardous pollutants in modern environmental health. Their resistance to degradation allows them to linger in soil, water, and the human body for decades, raising global alarm over their potential health impacts. In the United Kingdom, growing attention is being directed toward military bases such as RAF Marham, RM Chivenor, and AAC Middle Wallop, where historical PFAS use may be contaminating nearby drinking water sources. As investigations begin, communities and environmental experts alike are demanding accountability and urgent action.

What Are PFAS and Why They Matter

PFAS, or per- and polyfluoroalkyl substances, are a group of over 4,000 synthetic chemicals used since the 1940s in a wide array of consumer products, including non-stick cookware, water-resistant fabrics, and food packaging. Their chemical structure, characterized by strong carbon-fluorine bonds, makes them incredibly resistant to heat, oil, water, and degradation—earning them the nickname "forever chemicals."

While their industrial utility is undeniable, the environmental and health consequences are increasingly concerning. PFAS are known to accumulate in the human body over time, with exposure linked to a range of adverse health outcomes, including certain cancers, immune system suppression, hormonal disruptions, liver damage, and reproductive issues. Once released into the environment, PFAS persist in soil and water, infiltrating food chains and drinking water supplies.

In the UK, routine environmental monitoring has lagged behind other nations, leaving many regions potentially unaware of existing contamination. This is especially troubling in light of new studies suggesting widespread PFAS presence in surface and groundwater. The risk is particularly acute around areas of historic industrial or military activity—such as air bases—where PFAS-laden firefighting foams were heavily used. Understanding what PFAS are and why they matter is a critical first step in addressing their growing threat.

The Military Connection

Military installations around the world have long used firefighting foams containing PFAS, particularly aqueous film-forming foams (AFFF), due to their effectiveness in suppressing high-intensity fuel fires. In the UK, this practice was especially prevalent during training exercises and emergency responses at air force and army bases. Over time, repeated use of these foams has led to significant PFAS buildup in the surrounding soil and water.

Recent investigations have focused on three UK military sites—RAF Marham in Norfolk, RM Chivenor in Devon, and AAC Middle Wallop in Hampshire. These bases are situated near sensitive environments and, in some cases, within proximity to drinking water catchment areas. Concerns are mounting that PFAS from these sites may be leaching into local water supplies, posing a long-term threat to both environmental and public health.

The Ministry of Defence (MoD) has acknowledged the potential for contamination and initiated assessments at the bases. However, critics argue that these efforts are reactive rather than preventative, pointing to the lack of transparency and historical oversight. The situation underscores the pressing need for comprehensive PFAS monitoring, particularly in areas tied to defense operations, where the use of hazardous chemicals was often extensive and underregulated.

Current Investigations and Public Concerns

The UK Ministry of Defence has launched investigations into the potential contamination at RAF Marham, RM Chivenor, and AAC Middle Wallop, following pressure from environmental watchdogs and local residents. Initial assessments are underway to determine the extent of PFAS pollution, particularly in nearby groundwater and soil. However, the MoD has yet to publish detailed findings or a clear action plan for remediation, drawing criticism for its perceived lack of urgency.

Environmental groups such as CHEM Trust and Friends of the Earth have voiced serious concerns about the health implications for communities living near these bases. They warn that prolonged exposure to PFAS-contaminated water can have irreversible effects, especially on vulnerable populations such as children and pregnant women. Local councils have echoed these concerns, calling for more rigorous testing and public disclosure of risks.

Some residents have expressed frustration over the MoD’s communication, citing fears about the safety of their drinking water and the long-term environmental damage. Calls for independent testing and an overhaul of the UK’s PFAS regulation framework are growing louder. The ongoing investigations have not only spotlighted legacy pollution from military activities but also raised questions about institutional accountability in managing environmental health risks.

Comparative Global Response

Globally, countries like the United States and Australia have taken more aggressive stances on PFAS contamination, especially where military sites are involved. In the U.S., the Department of Defense has identified hundreds of military facilities with confirmed or suspected PFAS releases, prompting large-scale testing and remediation efforts. Some states have implemented strict drinking water standards, and legal actions against PFAS manufacturers have resulted in multimillion-dollar settlements.

In contrast, the UK’s approach has been slower and less coordinated. While the Environment Agency has begun mapping high-risk PFAS sites, many water utilities still lack the infrastructure to filter out these chemicals effectively. Moreover, the absence of legally binding national standards for PFAS in drinking water creates regulatory ambiguity.

This disparity highlights the need for the UK to not only accelerate investigations and clean-up efforts but also to adopt best practices from international counterparts who are confronting PFAS challenges with greater transparency, urgency, and technical capacity.

What’s Next: Policy and Accountability

The growing evidence of PFAS contamination near UK military bases underscores an urgent need for stronger regulatory oversight and clearer accountability mechanisms. Environmental advocates are calling for legally enforceable PFAS limits in drinking water and a national strategy for testing and remediation. Additionally, experts stress the importance of upgrading water treatment infrastructure to handle these persistent pollutants.

There is also a growing push to shift the financial burden of cleanup from taxpayers to the chemical industry. The principle of “polluter pays” is gaining traction, with campaigners urging the UK government to hold PFAS manufacturers and major users accountable for historical and ongoing contamination.

Equally important is the demand for transparency. Communities have a right to know the risks they face and the steps being taken to address them. Without timely and open communication, trust in public institutions erodes. Meaningful policy reform and corporate accountability are essential to mitigating PFAS's long-term impact.

New Molnupiravir Covid Antiviral Treatment

Molnupiravir is a new antiviral treatment currently in Phase III of its clinical trials in the United Kingdom.

It was developed by the private company Mavenir Therapeutics and is ideal for people infected with HCV who have already completed therapy with an appropriate antiviral agent.

Molnupiravir Covid Treatment Advances In The Fight Against The Pandemic

Molnupiravir covid treatment is an antiviral drug that is effective in its treatment during the pandemic.

Early drug trials have shown a rapid onset action against the virus, and patients tolerate it well.

The United States Food and Drug Administration (FDA) has also approved its use for treating influenza A H1N1 virus infection in adults aged 18 years or older, including pregnant women.

Molnupiravir may also be used to treat other strains of pandemic flu viruses, including seasonal flu; however, there is currently no data from clinical trials that support this use.

Side effects from this treatment are typically mild and include headache, body aches, sore throat, cough, and fever which usually resolve within seven days after beginning treatment. The effects will become more evident as its use becomes more prevalent. However, rare cases have been reported where patients develop a severe respiratory illness such as pneumonia or death.

How Molnupiravir Covid Works To Combat The Virus

Molnupiravir is an antiviral medication given to patients twice a day for five days while infected with the omicron variant of Covid. 

The pill is taken by mouth daily and selected for patients with a higher risk of death or severe hospitalization from Covid, many with underlying ailments associated with age or other health conditions.

While early trials appeared to aid the recovery of treated patients significantly, the data still does not correlate with any significant decreases in covid associated death rates or hospital admissions. 

Side Effects Of Covid Drugs And How To Minimize The

Covid drugs can cause various side effects, some of which have been serious and others with unknown long-term consequences.

Be sure to speak with your doctor or pharmacist about any potential side effects before starting this treatment, as there are many types of recovery aids to help those outside of high-risk categories.

Side effects of the new medication can include nausea, vomiting, diarrhea, and stomach pain which should all be communicated to your primary physician. 

Some people taking the drug have also experienced changes in their mood or behavior, but any increase in anxiety or depressive symptoms should be addressed immediately by a doctor.

Make sure to notify your doctor if you are using other medications concurrently that could interact with the Covid drug(s) you are prescribed.

Consult a healthcare professional if there is unexplained weight loss or increased appetite when using this coronavirus therapy. The drug has also been shown to react differently with diabetic patients with an increased risk for hypoglycemia and low blood sugar, which may impair the body’s renal function. 

The Current Status Of Covid Treatment And Future Prospects

The current status of this new Covid treatment is highly effective against the virus, with a 95% successful recovery rate in the usual two-week recovery period.

Critics of the therapy suggest many of the unwanted side effects make this treatment undesirable for patients outside high-risk categories. 

There has been significant research in the past few years to find new and better ways to treat Covid, which may improve the success rate even more in the future, and this is just one of those treatments.

Prospects for Covid treatment are very positive as new technologies are being developed all the time.

Patient Outcomes Following Administration Of Covid Therapies

Covid antiviral treatments have resulted in a marked decrease in patients developing illness complications and death.

The use of Covid therapies has also led to a significant reduction in the spread of the virus, meaning that fewer people are affected by it at any time. The resulting decrease in the transmission is due to the shortening of the recovery period and lessening the duration of transmissible symptoms like coughing.

While some risks are still associated with using Covid therapies, these have been significantly reduced over time as researchers continue to develop new ways to prevent severe complications from the pandemic virus.

Patients who receive Covid therapy often experience faster recoveries than those patients who do not receive treatment.

Overall, patient outcomes following the administration of Covid therapies are very positive and demonstrate clear benefits for both infected individuals and society as a whole.

Lessons Learned From Molnupiravir Covid Trials

1. Antiviral treatments are not a cure-all and should always be combined with other therapies to take advantage of their potential best.

2. New, more effective antiviral treatments are being developed continuously, and patients should remain informed about available options.

3. Many different side effects can occur when taking antiviral medications, but most tend to be mild and short-term.

4. Patients need to remain as active as possible while on an antiviral medication to reduce the risk of complications from the virus or the treatment itself (i.e., build-up of drug resistance).

UK Companies Overwhelmingly Favor Retaining EU Health & Safety Regulatory Regime Post-Brexit, EEF Survey Says

The EEF manufacturers’ organisation survey revealed that 97% of UK companies prefer avoiding an immediate post-Brexit divergence of the UK’s H&S regulatory regime from the EU; however, a slim majority of companies favor a review of the necessity of all current H&S regulations.

Read More

Cross-Industry Group of UK Organisations Commits to Limiting Silica Exposure

On December 4, the UK Institution of Occupational Safety and Health (IOSH) announced that a cross-industry group of organisations in the UK has committed to limiting employees' exposure to respirable crystalline silica (RCS), which, according to IOSH, is responsible for nearly 800 deaths in the UK each year.

Read More